COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu

A Trial Using CD133 Enriched Bone Marrow Cells Following Primary Angioplasty for Acute Myocardial Infarction (SELECT-AMI)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00529932
Recruitment Status : Terminated (Insufficient recruitment)
First Posted : September 14, 2007
Last Update Posted : April 22, 2015
King's College London
Information provided by (Responsible Party):
Jozef Bartunek, Onze Lieve Vrouw Hospital

No Study Results Posted on for this Study
Recruitment Status : Terminated
Actual Primary Completion Date : December 2011
Actual Study Completion Date : December 2012